NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 964 coverGENETICALLY ENGINEERED FOODS: ASSESSING POTENTIAL ALLERGENICITY Copyright © 2002 by the New York Academy of Sciences
description

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via Google Scholar
Google Scholar
Articles by POULSEN, L. K.
Search for Related Content
PubMed
PubMed Citation
Articles by POULSEN, L. K.
Annals of the New York Academy of Sciences 964:185-196 (2002)
© 2002 New York Academy of Sciences

Prediction of Allergenicity of Gene-Modified Foods by Serum-Based Testing

LARS K. POULSEN

Laboratory of Medical Allergology, National University Hospital, DK-2100 Copenhagen, Denmark

Address for correspondence: Lars K. Poulsen, Ph.D., Laboratory of Medical Allergology, National University Hospital, Dept. 7551, 9 Blegdamsvej, DK-2100 Copenhagen O, Denmark. fax: +45 35 45 75 81.
lkpallgy{at}inet.uni2.dk
Ann. N.Y. Acad. Sci. 964: 185-196 (2002).

On the basis of applying the IFBC/ILSI decision tree in a number of cases, a refinement of the scheme is suggested. Large differences in allergenic potential may be obtained by altering the route of administration of an allergen. Because an inhalation allergen can induce symptoms at different threshold doses depending on whether it is introduced via the inhalation or oral route, we propose that double-blind, placebo-controlled food challenges be performed in all cases of inhalation allergens being present in foods. Even proteins never previously ingested may cause IgE binding and elicit clinically relevant symptoms.

Key Words: serum-based testing • animal models • allergenicity • basophils • antibody binding • double-blind, placebo-controlled food challenges inhalation allergen • risk assessment






footerLeft footerRight